English

DUSA PHARMACEUTICALS INC

EDGAR

DUSA Quarterly report (10-Q) · filed 2012-11-09

69 filing records in this dataset, filed from 1996-08-12 to 2012-11-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.26 million USD

2004-03-31 · USD

Exact inputs and evidence

Revenue: 1255685 USD Source

Operating margin

-382.32%

2004-03-31 · %

Exact inputs and evidence

Operating Income: -4800791 USD Source
Revenue: 1255685 USD Source

Operating cash flow

-3.47 million USD

2004-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -3471619 USD Source

Free cash flow

-3.69 million USD

2004-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -3471619 USD Source
Capital Expenditure: 222516 USD Source

Cash and cash equivalents: 28.7 million USD 2012-09-30 Source
Exact value

28735654 USD
Long-term debt including current maturities: Not available
Shares outstanding: 25 million shares 2012-09-30 Source
Exact value

25027683 shares

Reported share-count change

1.53% · 378 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

24649364 shares · 2011-09-30· Source
25027683 shares · 2012-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.08 million USD

2003-04-01 – 2004-03-31

Exact inputs and evidence

Revenue: 147275 USD · 2003-04-01 – 2003-06-30 Source
Revenue: 163155 USD · 2003-07-01 – 2003-09-30 Source
Revenue: 970109 USD · 2003-01-01 – 2003-12-31 Source
Revenue: 453800 USD · 2003-01-01 – 2003-09-30 Source
Revenue: 1255685 USD · 2004-01-01 – 2004-03-31 Source

Net income

3.73 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Net income: 7319602 USD · 2011-01-01 – 2011-12-31 Source
Net income: 4012590 USD · 2011-01-01 – 2011-09-30 Source
Net income: -337122 USD · 2012-01-01 – 2012-03-31 Source
Net income: 2184929 USD · 2012-04-01 – 2012-06-30 Source
Net income: -1421469 USD · 2012-07-01 – 2012-09-30 Source

Operating cash flow

8.74 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: 8039264 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: 4041106 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: 1222644 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 3831937 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: 1222644 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 4740167 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: 3831937 USD · 2012-01-01 – 2012-06-30 Source

Capital expenditure

689 thousand USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Capital expenditure: 463557 USD · 2011-01-01 – 2011-12-31 Source
Capital expenditure: 271078 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 182766 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 485477 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 182766 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 496382 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 485477 USD · 2012-01-01 – 2012-06-30 Source

Free cash flow

8.05 million USD

2011-10-01 – 2012-09-30

Exact inputs and evidence

Operating cash flow: 8039264 USD · 2011-01-01 – 2011-12-31 Source
Operating cash flow: 4041106 USD · 2011-01-01 – 2011-09-30 Source
Operating cash flow: 1222644 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 3831937 USD · 2012-01-01 – 2012-06-30 Source
Operating cash flow: 1222644 USD · 2012-01-01 – 2012-03-31 Source
Operating cash flow: 4740167 USD · 2012-01-01 – 2012-09-30 Source
Operating cash flow: 3831937 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 463557 USD · 2011-01-01 – 2011-12-31 Source
Capital expenditure: 271078 USD · 2011-01-01 – 2011-09-30 Source
Capital expenditure: 182766 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 485477 USD · 2012-01-01 – 2012-06-30 Source
Capital expenditure: 182766 USD · 2012-01-01 – 2012-03-31 Source
Capital expenditure: 496382 USD · 2012-01-01 – 2012-09-30 Source
Capital expenditure: 485477 USD · 2012-01-01 – 2012-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-11-09.

Financial data available through: 2011-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2004-12-31
Operating income: 11 of 11 periods available· newest 2011-12-31
Net income: 11 of 11 periods available· newest 2011-12-31
Operating cash flow: 11 of 11 periods available· newest 2011-12-31
Capital expenditure: 11 of 11 periods available· newest 2011-12-31
Total assets: 11 of 11 periods available· newest 2011-12-31
Total liabilities: 11 of 11 periods available· newest 2011-12-31
Current assets: 11 of 11 periods available· newest 2011-12-31
Current liabilities: 11 of 11 periods available· newest 2011-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2011-12-31
long term debt: No compatible figures in this window
Shares outstanding: 2 of 11 periods available· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+170.8%

Prior period

USD 2.7 million

2010-01-01 – 2010-12-31
Current period

USD 7.32 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

7319602 − 2702617 = 4616985 USD

2702617 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
7319602 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · DUSA PHARMACEUTICALS INC · 2011-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Year-over-year change in Net income: 4616985 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 7319602 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#34918 Filing: 000119312512098873 Input fundies:NetIncome: 2702617 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#35035 Filing: 000119312512098873
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+141.8%

Prior period

USD 3.32 million

2010-01-01 – 2010-12-31
Current period

USD 8.04 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

8039264 − 3324382 = 4714882 USD

3324382 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
8039264 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · DUSA PHARMACEUTICALS INC · 2011-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Year-over-year change in Operating cash flow: 4714882 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 8039264 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#59665 Filing: 000119312512098873 Input fundies:OperatingCashFlow: 3324382 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#59840 Filing: 000119312512098873
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+115%

Prior period

USD 215,633

2010-01-01 – 2010-12-31
Current period

USD 463,557

2011-01-01 – 2011-12-31

Exact inputs and evidence

463557 − 215633 = 247924 USD

215633 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
463557 USD · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · DUSA PHARMACEUTICALS INC · 2011-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Year-over-year change in Capital expenditure: 247924 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 463557 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#61712 Filing: 000119312512098873 Input fundies:CapitalExpenditure: 215633 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#61886 Filing: 000119312512098873
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2004 2004-01-01 – 2004-12-31

Revenue USD 7.99 million 100% of revenue
Operating costs Derived USD 25.2 million 315% of revenue
Operating income −USD 17.21 million −215% of revenue
Tax, interest and other Derived −USD 1.58 million −20% of revenue
Net income −USD 15.63 million −196% of revenue

Cash

Operating cash flow −USD 14.07 million −176% of revenue
Capital expenditure USD 529,707 6.6% of revenue
Free cash flow Derived −USD 14.6 million −183% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Net income was higher than operating income, so the split is not drawn.
2003 Operating loss: operating costs were 1,827% of revenue.
2004 Operating loss: operating costs were 315% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	25483238	22966069 Derived	2517169	-3245349 Derived	5762518	-14408211 Derived	Source 2002-01-01 – 2002-12-31: 25483238 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 2517169 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: 5762518 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -11786053 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 2622158 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	970109	17723294 Derived	-16753185	-1926331 Derived	-14826854	-13393771 Derived	Source 2003-01-01 – 2003-12-31: 970109 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -16753185 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -14826854 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -12761117 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 632654 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	7987656	25196383 Derived	-17208727	-1579747 Derived	-15628980	-14597682 Derived	Source 2004-01-01 – 2004-12-31: 7987656 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -17208727 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -15628980 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -14067975 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 529707 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 8M 2004

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	5390736	Revenue: 5390736 Open source
20022002-12-31	Revenue	25483238	Revenue: 25483238 Open source
20032003-12-31	Revenue	970109	Revenue: 970109 Open source
20042004-12-31	Revenue	7987656	Revenue: 7987656 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

723.4% 2004

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	No prior comparable period	Revenue: 5390736 Open source
20022002-12-31	Year over year	372.7%	Revenue: 25483238 Open source Revenue: 5390736 Open source
20032003-12-31	Year over year	-96.2%	Revenue: 970109 Open source Revenue: 25483238 Open source
20042004-12-31	Year over year	723.4%	Revenue: 7987656 Open source Revenue: 970109 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -215.4% 2004

Net margin -195.7% 2004

Free cash flow margin -182.8% 2004

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Operating margin	-207.8%	Operating Income: -11202956 Open source Revenue: 5390736 Open source
20022002-12-31	Operating margin	9.9%	Operating Income: 2517169 Open source Revenue: 25483238 Open source
20032003-12-31	Operating margin	-1,726.9%	Operating Income: -16753185 Open source Revenue: 970109 Open source
20042004-12-31	Operating margin	-215.4%	Operating Income: -17208727 Open source Revenue: 7987656 Open source
20012001-12-31	Net margin	-136.5%	Net Income: -7358096 Open source Revenue: 5390736 Open source
20022002-12-31	Net margin	22.6%	Net Income: 5762518 Open source Revenue: 25483238 Open source
20032003-12-31	Net margin	-1,528.4%	Net Income: -14826854 Open source Revenue: 970109 Open source
20042004-12-31	Net margin	-195.7%	Net Income: -15628980 Open source Revenue: 7987656 Open source
20012001-12-31	Free cash flow margin	Not reported	Revenue: 5390736 Open source
20022002-12-31	Free cash flow margin	-56.5%	Revenue: 25483238 Open source Operating Cash Flow: -11786053 Open source Capital Expenditure: 2622158 Open source
20032003-12-31	Free cash flow margin	-1,380.6%	Revenue: 970109 Open source Operating Cash Flow: -12761117 Open source Capital Expenditure: 632654 Open source
20042004-12-31	Free cash flow margin	-182.8%	Revenue: 7987656 Open source Operating Cash Flow: -14067975 Open source Capital Expenditure: 529707 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14.1M 2004

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	Not reported	No source recorded
20022002-12-31	Operating cash flow	-11786053	Operating Cash Flow: -11786053 Open source
20032003-12-31	Operating cash flow	-12761117	Operating Cash Flow: -12761117 Open source
20042004-12-31	Operating cash flow	-14067975	Operating Cash Flow: -14067975 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -14.6M 2004

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	Unavailable	No source recorded
20022002-12-31	Free cash flow	-14408211	Operating Cash Flow: -11786053 Open source Capital Expenditure: 2622158 Open source
20032003-12-31	Free cash flow	-13393771	Operating Cash Flow: -12761117 Open source Capital Expenditure: 632654 Open source
20042004-12-31	Free cash flow	-14597682	Operating Cash Flow: -14067975 Open source Capital Expenditure: 529707 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

7.3% 2004

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Liabilities / assets	34.3%	Total Liabilities: 26029684 Open source Total Assets: 75864221 Open source
20022002-12-31	Liabilities / assets	8%	Total Liabilities: 4892243 Open source Total Assets: 60949973 Open source
20032003-12-31	Liabilities / assets	10%	Total Liabilities: 4465439 Open source Total Assets: 44697488 Open source
20042004-12-31	Liabilities / assets	7.3%	Total Liabilities: 4143870 Open source Total Assets: 56650888 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

13.34× 2004

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Current assets / current liabilities	22.76×	Current Assets: 69442903 Open source Current Liabilities: 3050522 Open source
20022002-12-31	Current assets / current liabilities	15.49×	Current Assets: 52266077 Open source Current Liabilities: 3374743 Open source
20032003-12-31	Current assets / current liabilities	11.52×	Current Assets: 37055846 Open source Current Liabilities: 3217939 Open source
20042004-12-31	Current assets / current liabilities	13.34×	Current Assets: 52751980 Open source Current Liabilities: 3953431 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	USD 5.76 million Exact value Exact value: 5762518 USD 2002-01-01 – 2002-12-31: 5762518 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2002-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: 5762518 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5762518 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0001104659-05-011142.txt#13873 The citation records this snapshot. The page link may show a newer release later.	−USD 11.79 million Exact value Exact value: -11786053 USD 2002-01-01 – 2002-12-31: -11786053 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2002-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: -11786053 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11786053 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0001104659-05-011142.txt#14353 The citation records this snapshot. The page link may show a newer release later.	USD 2.62 million Exact value Exact value: 2622158 USD 2002-01-01 – 2002-12-31: 2622158 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2002-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 2622158 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2622158 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0001104659-05-011142.txt#14485 The citation records this snapshot. The page link may show a newer release later.	−USD 14.41 million Calculation and evidence -11786053 − 2622158 USD Exact free cash flow: -14408211 USD 2002-01-01 – 2002-12-31: -11786053 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 2622158 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2002-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: -14408211 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11786053 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0001104659-05-011142.txt#14353 Input fundies:CapitalExpenditure: 2622158 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0001104659-05-011142.txt#14485 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 14.83 million Exact value Exact value: -14826854 USD 2003-01-01 – 2003-12-31: -14826854 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2003-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: -14826854 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14826854 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-06-002891.txt#4913 The citation records this snapshot. The page link may show a newer release later.	−USD 12.76 million Exact value Exact value: -12761117 USD 2003-01-01 – 2003-12-31: -12761117 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2003-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: -12761117 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12761117 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-06-002891.txt#4933 The citation records this snapshot. The page link may show a newer release later.	USD 632,654 Exact value Exact value: 632654 USD 2003-01-01 – 2003-12-31: 632654 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2003-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 632654 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 632654 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-06-002891.txt#4940 The citation records this snapshot. The page link may show a newer release later.	−USD 13.39 million Calculation and evidence -12761117 − 632654 USD Exact free cash flow: -13393771 USD 2003-01-01 – 2003-12-31: -12761117 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 632654 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2003-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: -13393771 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12761117 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-06-002891.txt#4933 Input fundies:CapitalExpenditure: 632654 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-06-002891.txt#4940 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 15.63 million Exact value Exact value: -15628980 USD 2004-01-01 – 2004-12-31: -15628980 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2004-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: -15628980 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15628980 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-07-004019.txt#14050 The citation records this snapshot. The page link may show a newer release later.	−USD 14.07 million Exact value Exact value: -14067975 USD 2004-01-01 – 2004-12-31: -14067975 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2004-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: -14067975 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14067975 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-07-004019.txt#14346 The citation records this snapshot. The page link may show a newer release later.	USD 529,707 Exact value Exact value: 529707 USD 2004-01-01 – 2004-12-31: 529707 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2004-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 529707 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 529707 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-07-004019.txt#14456 The citation records this snapshot. The page link may show a newer release later.	−USD 14.6 million Calculation and evidence -14067975 − 529707 USD Exact free cash flow: -14597682 USD 2004-01-01 – 2004-12-31: -14067975 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 529707 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2004-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: -14597682 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14067975 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-07-004019.txt#14346 Input fundies:CapitalExpenditure: 529707 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-07-004019.txt#14456 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 15 million Exact value Exact value: -14998709 USD 2005-01-01 – 2005-12-31: -14998709 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2005-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: -14998709 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14998709 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-08-002789.txt#14497 The citation records this snapshot. The page link may show a newer release later.	−USD 14.1 million Exact value Exact value: -14100945 USD 2005-01-01 – 2005-12-31: -14100945 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2005-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: -14100945 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14100945 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-08-002789.txt#14837 The citation records this snapshot. The page link may show a newer release later.	USD 415,168 Exact value Exact value: 415168 USD 2005-01-01 – 2005-12-31: 415168 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2005-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 415168 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 415168 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-08-002789.txt#14947 The citation records this snapshot. The page link may show a newer release later.	−USD 14.52 million Calculation and evidence -14100945 − 415168 USD Exact free cash flow: -14516113 USD 2005-01-01 – 2005-12-31: -14100945 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 415168 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2005-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: -14516113 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14100945 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-08-002789.txt#14837 Input fundies:CapitalExpenditure: 415168 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-08-002789.txt#14947 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 31.35 million Exact value Exact value: -31349507 USD 2006-01-01 – 2006-12-31: -31349507 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2006-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: -31349507 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31349507 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-09-004456.txt#27894 The citation records this snapshot. The page link may show a newer release later.	−USD 8.73 million Exact value Exact value: -8726865 USD 2006-01-01 – 2006-12-31: -8726865 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2006-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: -8726865 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8726865 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-09-004456.txt#28842 The citation records this snapshot. The page link may show a newer release later.	USD 212,669 Exact value Exact value: 212669 USD 2006-01-01 – 2006-12-31: 212669 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2006-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 212669 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 212669 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-09-004456.txt#29143 The citation records this snapshot. The page link may show a newer release later.	−USD 8.94 million Calculation and evidence -8726865 − 212669 USD Exact free cash flow: -8939534 USD 2006-01-01 – 2006-12-31: -8726865 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 212669 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2006-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: -8939534 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8726865 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-09-004456.txt#28842 Input fundies:CapitalExpenditure: 212669 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-09-004456.txt#29143 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 14.71 million Exact value Exact value: -14713507 USD 2007-01-01 – 2007-12-31: -14713507 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2007-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: -14713507 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14713507 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-10-021060.txt#13284 The citation records this snapshot. The page link may show a newer release later.	−USD 4.99 million Exact value Exact value: -4986118 USD 2007-01-01 – 2007-12-31: -4986118 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2007-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: -4986118 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4986118 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-10-021060.txt#13584 The citation records this snapshot. The page link may show a newer release later.	USD 246,760 Exact value Exact value: 246760 USD 2007-01-01 – 2007-12-31: 246760 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2007-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 246760 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 246760 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-10-021060.txt#13674 The citation records this snapshot. The page link may show a newer release later.	−USD 5.23 million Calculation and evidence -4986118 − 246760 USD Exact free cash flow: -5232878 USD 2007-01-01 – 2007-12-31: -4986118 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 246760 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2007-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: -5232878 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4986118 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-10-021060.txt#13584 Input fundies:CapitalExpenditure: 246760 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-10-021060.txt#13674 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 6.25 million Exact value Exact value: -6250441 USD 2008-01-01 – 2008-12-31: -6250441 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2008-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: -6250441 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6250441 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-11-021749.txt#26458 The citation records this snapshot. The page link may show a newer release later.	−USD 2.3 million Exact value Exact value: -2303243 USD 2008-01-01 – 2008-12-31: -2303243 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2008-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: -2303243 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2303243 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-11-021749.txt#27276 The citation records this snapshot. The page link may show a newer release later.	USD 365,421 Exact value Exact value: 365421 USD 2008-01-01 – 2008-12-31: 365421 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2008-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 365421 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 365421 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-11-021749.txt#27534 The citation records this snapshot. The page link may show a newer release later.	−USD 2.67 million Calculation and evidence -2303243 − 365421 USD Exact free cash flow: -2668664 USD 2008-01-01 – 2008-12-31: -2303243 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 365421 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2008-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: -2668664 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2303243 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-11-021749.txt#27276 Input fundies:CapitalExpenditure: 365421 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/0000950123-11-021749.txt#27534 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 2.51 million Exact value Exact value: -2508292 USD 2009-01-01 – 2009-12-31: -2508292 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2009-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: -2508292 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2508292 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#35152 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	−USD 1.78 million Exact value Exact value: -1782417 USD 2009-01-01 – 2009-12-31: -1782417 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2009-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: -1782417 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1782417 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#60015 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	USD 178,308 Exact value Exact value: 178308 USD 2009-01-01 – 2009-12-31: 178308 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2009-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 178308 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 178308 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#62060 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	−USD 1.96 million Calculation and evidence -1782417 − 178308 USD Exact free cash flow: -1960725 USD 2009-01-01 – 2009-12-31: -1782417 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 178308 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2009-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: -1960725 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1782417 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#60015 Filing: 000119312512098873 Input fundies:CapitalExpenditure: 178308 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#62060 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 2.7 million Exact value Exact value: 2702617 USD 2010-01-01 – 2010-12-31: 2702617 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2010-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: 2702617 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2702617 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#35035 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	USD 3.32 million Exact value Exact value: 3324382 USD 2010-01-01 – 2010-12-31: 3324382 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2010-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: 3324382 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3324382 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#59840 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	USD 215,633 Exact value Exact value: 215633 USD 2010-01-01 – 2010-12-31: 215633 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2010-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 215633 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 215633 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#61886 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	USD 3.11 million Calculation and evidence 3324382 − 215633 USD Exact free cash flow: 3108749 USD 2010-01-01 – 2010-12-31: 3324382 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 215633 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2010-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: 3108749 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3324382 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#59840 Filing: 000119312512098873 Input fundies:CapitalExpenditure: 215633 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#61886 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	USD 7.32 million Exact value Exact value: 7319602 USD 2011-01-01 – 2011-12-31: 7319602 USD Inspect Net Income Open source Share or cite Citation for Net Income · DUSA PHARMACEUTICALS INC · 2011-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Net Income: 7319602 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7319602 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#34918 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	USD 8.04 million Exact value Exact value: 8039264 USD 2011-01-01 – 2011-12-31: 8039264 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · DUSA PHARMACEUTICALS INC · 2011-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Operating Cash Flow: 8039264 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 8039264 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#59665 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	USD 463,557 Exact value Exact value: 463557 USD 2011-01-01 – 2011-12-31: 463557 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · DUSA PHARMACEUTICALS INC · 2011-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Capital Expenditure: 463557 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 463557 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#61712 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.	USD 7.58 million Calculation and evidence 8039264 − 463557 USD Exact free cash flow: 7575707 USD 2011-01-01 – 2011-12-31: 8039264 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 463557 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · DUSA PHARMACEUTICALS INC · 2011-12-31 DUSA PHARMACEUTICALS INC (edgar:879993) Free cash flow: 7575707 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T09:19:19Z Snapshot: 3e30444a4216581077c44f423ce8be06ef2be4055b160acf7d3e4d2760732832 Dimensions: Consolidated View: https://fundies.io/companies/edgar/879993?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 8039264 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#59665 Filing: 000119312512098873 Input fundies:CapitalExpenditure: 463557 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/879993/000119312512098873/dusa-20111231.xml#61712 Filing: 000119312512098873 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

69 filings · 517 latest values · 517 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000879993, 879993, DUSA, edgar:879993

Also known as DUSA PHARMACEUTICALS INC

DUSA PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2004 2004-01-01 – 2004-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation